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Structure and Heterogeneity of the Human Gene for Epiplakin
(EPPK1)
To the Editor:
Almost all known members of the plakin family, for example
BPAG1, desmoplakin, envoplakin, periplakin, and plectin, can
be targets of a patient’s antibodies in several autoimmune blister-
ing diseases and these plakins are, in fact, used as markers for spe-
ci¢c diseases (Sawamura et al, 1991;Tanaka et al, 1991; Oursler et al,
1992; Kim et al, 1997; Mahony et al, 1998; Proby et al, 1999). Some
members of this family have a common structure, with predicted
globular amino-terminal and carboxy-terminal domains that are
separated by a central rod domain. Some homologous domain
structures have been identi¢ed in both globular domains of many
plakins, whereas the central domain is rich in heptad repeats and
is believed to form a parallel a-helical coiled-coil structure with a
dimerization partner (Green et al, 1992; Leung et al, 2002).
Epiplakin, which was recently identi¢ed as an autoantigen in
serum from a patient with subepidermal blistering diseases, is
also a member of the plakin family and the message size of this
protein was more than 12 to 13 kb (Fujiwara et al, 1992, 1996). Mo-
lecular cloning of epiplakin demonstrated that it is a protein of
5065 amino acids with a molecular mass of 552 kDa. Moreover,
it has some very unusual features; for example, it has 13 domains
that are homologous to the B domain in the carboxy-terminal
region of desmoplakin. The last ¢ve of these 13 B domains, to-
gether with their associated linker regions, are particularly
strongly conserved. Moreover, epiplakin lacks a coiled-coil rod
domain and an amino-terminal domain, both of which are found
in all other known members of the plakin family and, in addi-
tion, no dimerization motif is evident in the sequence. Thus, it
is likely that epiplakin exists in vivo as a single-chain structure
(Fujiwara et al, 2001).
We report here the isolation of the human gene for epiplakin
from a genomic library and an analysis of its structure. We
screened a human genomic library, constructed from leukocytes,
with the insert of the cDNA clone Ep21, which were obtained
from a HeLa cell library, as described in a previous report (Fuji-
wara et al, 2001).We isolated one genomic clone, NT2, and this
clone hybridized with another cDNA clone pE450-D, con¢rm-
ing that we had isolated a gene for epiplakin.We used the 30 end
of Ep12 cDNA for isolation of another genomic clone, NT4.This
clone overlapped with NT2 (Fig 1). In order to con¢rm the ex-
tent of the strongly homologous repeats in the 30 region, we per-
formed genomic polymerase chain reaction to amplify the
repetitive region, using DNA from HeLa cells (HeLa5) or leuko-
cytes from a single individual (NTnt) as described previously
(Fujiwara et al, 2001). The lengths of DNA fragments obtained
from both ampli¢cations was identical and was slightly more
than 9 kb. The contig sequence that included the sequences of
NT2 and NT4 was 21.5 kb long and it included the entire open
reading frame for epiplakin (15,195 kb). No interruptions were
found from ATG to TGA and, thus, no introns were present.
There were 30 nucleotide di¡erences between the cDNA from
HeLa cells and the gene from the leukocyte library, 19 of which
would be expected to lead to amino acid substitutions.
There were nine or fewer GCC repeats that encoded polyala-
nine in the linker regions of the ¢ve homologous repeats at the 30
end of epiplakin cDNA.When we focused on the diversity of this
region, we found only two sites of di¡erences (repeats 4 and 5)
between the cDNA and the HeLa DNA; however, we found at
least four sites of di¡erences between genes from two di¡erent
sources namely, NT2 and NT4 versus HeLa5 or NT2 and NT4
versus NTnt (Table 1a). These data suggested diversity among in-
dividuals in these microsatellite regions, which we were able to
demonstrate as follows. We isolated DNA from 15 genetically
nonrelated healthy Japanese and ampli¢ed the ¢rst of ¢ve homo-
logous repeats in the gene for epiplakin by nested polymerase
chain reaction. Eight GCC repeats were the most frequent and
were found in 15 chromosomes and, in ¢ve of these chromo-
somes, there was a G to A transition in the ¢fth GCC repeat. Five
GCC repeats were found in nine chromosomes, and nine GCC
repeats were found in six chromosomes, in one of which there
was a G to A transition in the seventh GCC repeat (Table 1b).
We mapped the gene for epiplakin on human chromosomes by
the published procedure (Feng et al, 1994) using the genomic
clone NT2. Under our conditions, the e⁄ciency of detection of
signals due to £uorescence in situ hybridization was approxi-
mately 87% with our chosen probe (among 100 mitotic ¢gures
examined, 87 yielded hybridization signals on one pair of chro-
mosomes). The gene was mapped to the q24.3 region of human
chromosome 8 (data not shown).
Figure1. Cloning strategy for the isolation and sequencing of the
human gene for epiplakin and schematic representation of the
deduced protein.The genomic clones isolated in this study allowed iden-
ti¢cation of one exon, which corresponded to contiguous cDNA se-
quences. Three cDNA probes, namely Ep21, pE450-D, and the 30 end of
Ep12 (Ep12-30), are also shown. The ¢ve homologous repeats at the 30 end
of the gene for epiplakin were ampli¢ed by polymerase chain reaction
using DNA from leukocytes (NTnt) and from HeLa cells (HeLa5). On
the lowest diagram, the numbers at the top are domain numbers; the num-
bers under the line below the boxes show the distance between domains
(in terms of amino acid residues). Boxes indicate B domains that are 70-
46% homologous to the B domain in desmoplakin (Fujiwara et al, 2001).
Double-lined linker regions and the ¢ve B domains (9^13) to their right
are almost identical. Small arrowheads indicate Xho sites and E indicates an
EcoRI site. Large arrowheads indicates the positions of GCC repeats. Dashed
lines indicate borders of ¢ve strongly conserved repeats at the 30 end.
The sequence of gene for Epiplakin (EPPK1) has been submitted to the
DNA Data Bank of Japan, accession number, AB107036.
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Epiplakin contains 13 B domains, which are 70-46% homolo-
gous to the B domain at the carboxyl terminus of desmoplakin,
and these domains are distributed along the sequence with rela-
tively uniform spacing. In the genes of other known members of
the plakin family, including desmoplakin, plectin, and BPAG1,
the carboxy-terminal domain is also encoded by one exon (Green
et al, 1999) and this rule is not broken in the case of epiplakin.The
polymorphism among individuals with respect to the ¢ve re-
peated structures in the gene for epiplakin might contribute to
the functional diversity of this region. Nine or less than nine
GCC repeats that encode polyalanine are localized in the linker
regions of the ¢ve homologous repeats in the human gene for
epiplakin. The B domain is strongly conserved between human
and mouse, although the linker region di¡ers considerably be-
tween these two species and the GCC repeats are unique to the
human genome (unpublished data). Thus, if genetic cutaneous
diseases with microsatellites of abnormal length, similar to those
in a trinucleotide repeat expansion disease in the central nervous
system (Ashley and Warren, 1995) were to exist, they would be
restricted to humans.
The gene for epiplakin mapped to chromosomal band 8q24.3,
which is close to the locus of the gene for plectin (Liu et al, 1996;
Mclean et al, 1996). According to the UCSC Human Genome
Browser (http://genome.ucsc.edu/) in April 2003, the speci¢c
location of the gene for epiplakin is the telomeric end of the long
arm of chromosome 8, consistent with our data, but the genomic
size of the gene for epiplakin was given as 7524 bp, which is a
major underestimate. Almost all the strongly conserved repeats
at the 30 end were missing, perhaps due to the limited ability of
the shot-gun sequencing method used in the international gen-
ome project. The distance between the gene for epiplakin and
that for plectin was estimated to be about 60 kb and only one
predicted gene is localized between them. Both genes are
oriented in the same directions and are transcribed towards the
centromeric end.The position of these two genes in relatively close
proximity suggests that they might be regulated coperatively.
Our mapping data exclude the possibility that the genomic
clones that we isolated might represent processed pseudogene(s),
even though they did not contain any introns. One mapped
locus, the absence of a paralog, and the absence of a polyadenylated
[poly(A)]tail suggest that retrotransposition of the gene for
epiplakin, in which spliced mRNAwould be reverse transcribed
and reinserted into the genome, is unlikely to have occurred in
the evolution of the gene for epiplakin.
The authors thank Dr Mohammed Khaleduzzaman for determining the nucleotide
sequences, MrTsuyoshi Kubo and Mr Koichi Kai for helpeful advice, and Ms Mami
Sakurai and Ms Michiyo Yoshimitsu for preparing the manuscript. This work was
supported in part by grants nos 07670954, 09670889, 11670839, and 13670892 (to
S. Fujiwara) from the Ministry of Education, Japan, and by a grant (to S.F) from
theTERUMO Life Science Foundation (Kanagawa, Japan).
NaokoTakeo, WenqingWang, Noritaka Matsuo, Hideaki
Sumiyoshi, HidekatsuYoshioka, and Sakuhei Fujiwara
Department of Anatomy, Biology and Medicine (Dermatology and
Biochemistry), Oita Medical University, 1 Idaigaoka, Hasama, Oita
879-5593, Japan
These authors contributed equally to the work.
REFERENCES
Ashley CT,Warren ST:Trinucleotide repeat expansion and human disease. Annu Rev
Genet 29:703^728, 1995
Feng GS, Shen R, Heng HHQ,Tsui LC, Kazlauskas A, PawsonT: Receptor-binding,
tyrosine phosphorylation and chromosome localization of the mouse SH2-
containing phosphotyrosine phosphatase Syp. Oncogene 9:1545^1550, 1994
Fujiwara S, Shinkai H, Takayasu S, Owaribe K, Tsukita S, Kageshita T: A case of
subepidermal blister disease associated with autoantibody against 450-kD pro-
tein. J Dermatol 19:610^613, 1992
Fujiwara S, Kohno K, Iwamatsu A, Naito I, Shinkai H: Identi¢cation of a 450-kD
human epidermal autoantigen as a new member of the plectin family. J Invest
Dermatol 106:1025^1030, 1996
Fujiwara S,Takeo N, Otani Y, et al: Epiplakin, a novel member of the plakin family
originally identi¢ed as a 450-kDa human epidermal autoantigen: Structure
and tissue localization. J Biol Chem 276:13340^13347, 2001
Green KJ, Virata MLA, Elgart GW, Stanley J, Parry DAD: Comparative structural
analysis of desmoplakin, bullous pemphigoid antigen and plectin: Members
of a new gene family involved in organization of intermediate ¢laments. Int J
Biol Macromol 14:145^153, 1992
Green KJ, Guy SG, Cserhalmi-Friedman PB, McLeanWHI, Christiano AM,Wagner
RM: Analysis of the desmoplakin gene reveals striking conservation with other
members of the plakin family of cytolinkers. Exp Dermatol 8:462^470, 1999
Kim SC, KwonYD, Lee IJ, Chang SN, LeeTG: cDNA cloning of the 210-kDa para-
neoplastic pemphigus antigen reveals that envoplakin is a component of the
antigen complex. J Invest Dermatol 109:365^369, 1997
Leung CL, Green KJ, Liem RKH: Plakins: A family of versatile cytolinker proteins.
Trends Cell Biol 12:37^45, 2002
Liu CG, Maercker C, Castanon MJ, Hauptmann R,Wiche G: Human plectin: Orga-
nization of the gene, sequence analysis, and chromosome localization (8q24).
Proc Natl Acad Sci USA 93:4278^4283, 1996
Table Ia. Variations between microsatellite sequences in genes and the cDNA for epiplakin.
There are GCC repeats in the ¢ve homologous repeats that encode linker regions between B domains (Fig. 1). There was a G to A
transition in some ¢fth and forth repeat. Numbers after parentheses indicate the numbers of GCC or ACC repeats. Only two sites of
di¡erences (repeats 4 and 5) were found when we compared cDNA and HeLa DNA. At least four sites of di¡erences were found
between genes from two di¡erent sources, NT2 plus NT4 versus HeLa5 or NTnt
Sequence/Repeat cDNA NT2 & NT4 NTnt HeLa5
1st (GCC) 8 (GCC) 5 (GCC) 9 (GCC) 8
2nd (GCC) 8 (GCC) 4 ACC (GCC) 3 (GCC) 9 (GCC) 8
3rd (GCC) 8 (GCC) 4 ACC (GCC) 3 (GCC) 8 (GCC) 8
4th (GCC) 4 ACC (GCC) 3 (GCC) 5 or (GCC) 9 (GCC) 8 (GCC) 8
5th (GCC) 8 (GCC) 8 (GCC) 8 (GCC) 3 ACC 2 (GCC) 3
Table Ib. Variations in the microsatellite sequence in the ¢rst
repeat of the gene for epiplakin among 15 individuals.
Eight repeats were most frequently found in 15 chromosomes,
in ¢ve of which there was a G to A transition in the ¢fth repeat.
Five GCC repeats were found in nine chromosomes and nine
repeats were found in six chromosomes, in one of which there
was a G to A transition in the seventh repeat. Numbers after
parentheses indicate the number of GCC repeats
Repeats Variation
Number of chromosomes in
which vaviation was found
5 (GCC) 5 9
8 (GCC) 8 10
(GCC) 4ACC (GCC) 3 5
9 (GCC) 9 5
(GCC) 6ACC (GCC) 2 1
LETTERS TO THE EDITOR 1225VOL. 121, NO. 5 NOVEMBER 2003
Mahony MG, Aho S, Uitto J, Stanley JR:The members of the plakin family of pro-
teins recognized by paraneoplastic pemphigus antibodies include periplakin. J
Invest Dermatol 111:308^313, 1998
Mclean WHI, Pulkkinen L, Smith FJD, et al: Loss of plectin causes epidermolysis
bullosa with muscular dystrophy: cDNA cloning and genomic organization.
Genes Dev 10:1724^1735, 1996
Oursler JR, Labib RS, Ariss-Abdo L, Burke T, O’Keefe EJ, Anhalt GJ: Human auto-
antibodies against desmoplakin in paraneoplastic pemphigus. J Clin Invest
89:1775^1782, 1992
Probg C, Fugii Y, Owaribe K, NishikawaT, Amagai M: Human autoantibodies against
HDI/plectin in paraneoplastic pemphigus. J Invest Dermatol 112:153^156, 1999
Sawamura D, Li K, Chu ML, Uitto J: Human bullous pemphigoid antigen (BPAG1)
amino acid sequences deduced from cloned cDNAs predict biologically impor-
tant peptide segments and protein domains. J Biol Chem 266:17784^17790, 1991
TanakaT, Parry DAD, Klaus-KovtunV, Steinert PM, Stanley J: Comparison of mo-
lecularly cloned bullous pemphigoid antigen to desmoplakin I con¢rms that
they de¢ne a new family of cell adhesion junction plaque proteins. J Biol Chem
266:12555^12559, 1991
Propionibacterium acnes-Reactive T Helper-1 Cells in the Skin of
Patients with AcneVulgaris
To the Editor:
Acne vulgaris is the commonest skin disorder to a¡ect humans,
characterized by both nonin£ammatory (comedones) and in£am-
matory lesions (papules, pustules, and nodulocystic lesions). It is a
disease of the pilosebaceous follicle with comedones resulting
from the hypercorni¢cation of the keratinocytes of the duct wall
and usually preceding in£ammatory lesions (Cunli¡e et al, 2000).
Of particular interest in the pathophysiology of in£ammatory
acne is the role of the normal skin commensal bacterium Propio-
nibacterium acnes. Although not a requirement for comedogenesis,
a number of observations have suggested that P. acnes is impli-
cated in the pathogenesis of in£ammatory acne. The density of
P. acnes increases markedly during puberty coinciding with the
onset of the disease (Leyden et al, 1975). P. acnes is rarely found in
animal skin and acne is not seen in animals (Webster et al, 1981;
Kearney et al, 1982). Treatments that reduce P. acnes numbers lead
to clinical improvement of acne (Thiboutot, 1997) and, ¢nally,
the emergence of antibiotic-resistant P. acnes strains are linked to
the failure of antibiotic treatment (Eady et al, 1989). The immu-
nostimulatory activity of P. acnes and resulting prototypicT help-
er 1 immune response has been widely studied in animal models
(Matsui et al, 1997; Okazaki et al, 2001); however, the speci¢city
and cytokine pro¢les of lesional Tcells from skin of acne patients
have not been investigated previously. Here we describe the gen-
eration of T cell lines (TCL) from in£amed acne lesions, and,
their proliferative and cytokine responses to P. acnes antigens.
Approval was granted for this research project by the Hammer-
smith Queen Charlotte’s & Chelsea and Actin Hospitals Research
Ethics Committee. Full consent was granted by subjects.
Fourteen TCL were generated from early papular in£amma-
tory acne lesions of 16 untreated patients, stained for CD4, CD8,
andTcell receptor ab expression and tested in proliferation assays
with P. acnes and control antigens (Fig 1). To determine their cy-
tokine pro¢le, TCL were stimulated with phorbal 12-myristate
13-acetate (PMA) plus ionomycin or P. acnes extract and stained
intracellularly for interferon (IFN)-g, interleukin (IL)-4, IL-5,
and IL-10 using £ow cytometry. Results were compared
with eight corresponding TCL generated in the same way from
lesional skin of 11 psoriatic patients.
Acne TCL consisted of T cell receptor abþ Tcells (96.474%)
with a predominance of CD4þ (9277.5%) phenotype, whereas
psoriatic TCL contained a higher percentage of CD8þ T cells
(24.8þ 21.4%; po0.05). This is in agreement with an earlier im-
munohistochemical study that demonstrated perivascular and
periductal in¢ltrates of CD4þ T cells in early acne skin lesions
(Layton et al, 1998); however, the stimulus for T cell in¢ltration
into acne lesions remains to be determined. The initial T cell
in¢ltrate may represent a speci¢c cell-mediated immune response
to P. acnes antigens within the ductal lumen. In support of this
hypothesis, this study has shown that all acne TCL proliferated
to P. acnes extract (optimal concentration 1:100) with a wide range
of responses (mean 642074545 cpm) (Fig 1). Anti-HLA-DR
Figure1. Increased proliferative response to P. acnes extract by acne
versus psoriatic TCL. TCL were established by culturing skin fragments
(4 mm acne skin biopsies or psoriasis shave biopsies) in RMPI 1640 med-
ium (Gibco BRL, Invitrogen Ltd, Paisley, UK) supplemented with 2 mM
L-glutamine, 100 U per mL penicillin and 100 mg streptomycin per mL
(Gibco BRL), and 10% human ABþ serum (complete medium) contain-
ing P. acnes extract (1:100 dilution), adding 20 U per mL human recombi-
nant IL-2 (Roche Molecular Biochemicals, Lewes, UK) every 3 d. After
14 d culture,TCL (2.5  104 per well) plus an equal number of irradiated,
autologous peripheral blood mononuclear cells were cultured for 3 d in the
presence or absence of optimal concentrations of each of the microbial pre-
parations in 96-well plates. Tritiated thymidine (4 mCi per mL, speci¢c ac-
tivity 5 Ci per mmol; Amersham International, Amersham, UK) was
added for the last 6 h of culture. The cells were harvested on to ¢berglass
paper, and the incorporated radioactivity measured in a b scintillation
counter. Proliferation was expressed as the mean cpm of three replicates in
the presence of microbial preparation minus the mean cpm of three repli-
cates in the absence of microbial preparation. Bars indicate the mean pro-
liferative response of each group.
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